Chronic kidney disease (CKD) is the most common disease in senior cats, affecting an estimated 30-40% of cats over 10 years old. Long-term quality of life management is essential as CKD is progressive and incurable.
CKD in cats involves a gradual decline in welfare that is manageable with appropriate intervention and requires ongoing quality-of-life assessment. The toxin accumulation of advanced CKD (uraemia) causes nausea, lethargy, and generalised malaise that significantly reduces a cat's engagement with normal activities and pleasures. The treatment burden — prescription diets, medications, and potentially twice-weekly subcutaneous fluid administration at home — must be weighed against quality-of-life benefit. Some cats tolerate home fluid administration well and maintain good quality of life at advanced CKD stages; others find the procedure distressing and this must factor into management decisions. Regular quality-of-life assessments using validated tools help owners and vets make humane decisions about treatment continuation and end-of-life timing.